Similar articles

• Melatonin, biological rhythm disorders and phototherapy.

  Srinivasan V. Srinivasan V. Indian J Physiol Pharmacol. 1997 Oct;41(4):309-28. Indian J Physiol Pharmacol. 1997. PMID: 10235654 Review.
• Melatonin and aging: relevance for clinical approach?

  Fauteck JD, Dittgen M, Farker K, Hoffmann A, Hoffmann H, Lerchl A, Wittkowski W. Fauteck JD, et al. J Endocrinol Invest. 1999;22(10 Suppl):90-1. J Endocrinol Invest. 1999. PMID: 10727065 No abstract available.
• Melatonin: from biochemistry to therapeutic applications.

  Zawilska JB, Nowak JZ. Zawilska JB, et al. Pol J Pharmacol. 1999 Jan-Feb;51(1):3-23. Pol J Pharmacol. 1999. PMID: 10389140 Review.
• Melatonin, its receptors, and relationships with biological rhythm disorders.

  Delagrange P, Guardiola-Lemaitre B. Delagrange P, et al. Clin Neuropharmacol. 1997 Dec;20(6):482-510. doi: 10.1097/00002826-199712000-00002. Clin Neuropharmacol. 1997. PMID: 9403224 Review.
• Alleic variants of human melatonin 1a receptor: function and prevalence in subjects with circadian rhythm sleep disorders.

  Ebisawa T, Kajimura N, Uchiyama M, Katoh M, Sekimoto M, Watanabe T, Ozeki Y, Ikeda M, Jodoi T, Sugishita M, Iwase T, Kamei Y, Kim K, Shibui K, Kudo Y, Yamada N, Toyoshima R, Okawa M, Takahashi K, Yamauchi T. Ebisawa T, et al. Biochem Biophys Res Commun. 1999 Sep 7;262(3):832-7. doi: 10.1006/bbrc.1999.1308. Biochem Biophys Res Commun. 1999. PMID: 10471411